“The vaccine will be prioritized for the frontline workers namely all health care professionals and all workers in the medical facilities,” state news agency Antara quoted Health Minister Terawan Agus Putranto as saying during a coordination meeting for the preparation of the vaccination program on September 30.
“The next priority will be given to people in the high-risk category, namely working population aged 18-59 years,” said Terawan in the meeting led by the Coordinating Maritime Affairs and Investment Minister Luhut Binsar Pandjaitan.
Terawan explained that the need for vaccination across the country reached 320 million doses. If measured by the vaccine usage index, however, the government should ideally provide 352 million doses of vaccine, he added.
“The supply of vaccines will be jointly carried out by the Ministry of Foreign Affairs, Ministry of State Owned Enterprises, BPOM [National Agency of Drug and Food Control], and BNPB [National Disaster Mitigation Agency],” said Terawan.
In the same meeting, Deputy State-Owned Enterprises Minister Budi Gunadi Sadikin said that currently, the ministry’s vaccine storage can store 123 million vaccines.
Therefore, the deputy minister said, state-owned pharmaceutical companies Bio Farma and Kimia Farma are working closely to provide a cold chain equipment inventory with a capacity of up to 300 million vaccines. This facility is being prepared for storing the Covid-19 vaccines from various foreign counterparts.
Meanwhile, Foreign Affairs Minister Retno Marsudi said there have been discussions with several countries regarding the supply of the Covid-19 vaccine. Those who have expressed commitment to provide vaccines for Indonesia are China, the United Arab Emirates, and the UK.
“We have communicated regularly with China, United Arab Emirates, and the UK to provide vaccines for Indonesia,” said Retno.
“We have also arranged for meetings with the countries to further review vaccine clinical trials and the production before the vaccines will be sent to Indonesia,” she added.
Head of BPOM Penny Kusumastuti Lukito said the technical team from her office will conduct site visits to see the ongoing clinical trials and production of vaccines in the laboratories. The meetings will also discuss the delivery system and halal certification of the Covid-19 vaccine, she said.
(Writer: Dian Erika Nugraheny | Editor: Diamanty Meiliana)https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.